Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin

Project Title Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin
Date Posted
Friday, January 24, 2020
Project ID
cder_mpl1r_wp130
Status
Complete
Deliverables
Sentinel Modular Program Report: Concurrent Use of Ticagrelor with Atorvastatin or Rosuvastatin
Related Links
2019 AHA Scientific Sessions Poster: Myopathy and Rhabdomyolysis with Concomitant Use of Ticagrelor and High-Intensity Statins in the Elderly
Description

In this report we evaluated concurrent use of ticagrelor (all strength, 60mg, and 90mg) with atorvastatin or rosuvastatin in the Sentinel Distributed Database (SDD).

The study period included data from January 1, 2012 to June 30, 2018. We distributed this request to 17 Data Partners on January 8, 2019.

Medical Product
atorvastatin
rosuvastatin
ticagrelor
Population / Cohort
All individuals
Time Period
January 1, 2012 - June 30, 2018
Assessment Type
Exploratory Analyses
Study Type
Modular Program
Data Sources
Sentinel Distributed Database (SDD)
FDA Center
CDER
Scroll to Top